<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Innov Clin Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Innov Clin Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">ICNS</journal-id>
<journal-title-group>
<journal-title>Innovations in Clinical Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">2158-8333</issn>
<issn pub-type="epub">2158-8341</issn>
<publisher>
<publisher-name>Matrix Medical Communications</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28386521</article-id>
<article-id pub-id-type="pmc">5373795</article-id>
<article-id pub-id-type="other">icns_14_1-2_53</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MicroRNAs as Biomarkers for Psychiatric Conditions: A Review of Current Research</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Narahari</surname>
<given-names>Anoop</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hussain</surname>
<given-names>Mariyah</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sreeram</surname>
<given-names>Venkatesh</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<aff>Drs. Narahari, Hussain, and Sreeram are from the University of Alabama, Department of Psychiatry and Behavioral sciences, Birmingham, Alabama.</aff>
</contrib-group>
<author-notes>
<corresp><bold>ADDRESS CORRESPONDENCE TO:</bold> Dr. Anoop Narahari, Department of Psychiatry &amp; Behavioral Neurobiology, University of Alabama at Birmingham, SC 1028, 1720 7th Avenue South, Birmingham, AL 35294-0017 Email address: <email xlink:type="simple">narahari@uab.edu</email></corresp>
<fn fn-type="COI-statement">
<p><bold>FINANCIAL DISCLOSURES:</bold>The authors have no conflicts of interest relevant to the content of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<season>Jan-Feb</season>
<year>2017</year>
</pub-date>
<volume>14</volume>
<issue>1-2</issue>
<fpage>53</fpage>
<lpage>55</lpage>
<permissions>
<copyright-statement>Copyright Â© 2017. Matrix Medical Communications. All rights reserved.</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>Neural-derived exosomes can be used as diagnostic markers to screen for various psychiatric conditions. These intravenously injected exosomes carry the potential to cross the blood brain barrier and deliver miRNA molecules specifically to neurons, microglia, and oligodendrocytes in the brain, resulting in specific gene knockdown. Here the authors review and discuss the current research on microRNA molecules and the therapeutic roles they may potentially play in treating depression, bipolar disorder, and schizophrenia.</p>
</abstract>
<kwd-group>
<kwd>MicroRNA (miR/miRNA)</kwd>
<kwd>messengerRNA (mRNA)</kwd>
<kwd>neuronal plasticity</kwd>
<kwd>neurogenesis</kwd>
<kwd>hippocampus</kwd>
<kwd>depression</kwd>
<kwd>bipolar disorder</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>